Who
Jeffrey Adam Novack
Secretary and General Counsel
Company insider
Files Form 4 as: Secretary and General Counsel, CareDx.
In numbers
- Trades disclosed
- 56
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $1.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 May 2024
- Last trade
- 1 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 5 Oct 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $66K997 at $66.23 | filing |
| 5 Aug 2026filed 6 Aug 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $101K2,188 at $46.15 | filing |
| 5 Aug 2026filed 6 Aug 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $23K500 at $46.75 | filing |
| 5 Aug 2026filed 6 Aug 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $101K2,188 at $46.15 | filing |
| 5 Aug 2026filed 6 Aug 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $23K500 at $46.75 | filing |
| 1 Aug 2026filed 4 Aug 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $137K2,872 at $47.85 | filing |
| 1 Aug 2026filed 4 Aug 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $137K2,872 at $47.85 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $29K997 at $29.25 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $29K997 at $29.25 | filing |
| 6 Jun 2026filed 9 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $28K1,292 at $21.95 | filing |
| 6 Jun 2026filed 9 Jun 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $28K1,292 at $21.95 | filing |
| 5 May 2026filed 6 May 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $56K2,688 at $20.68 | filing |
| 5 May 2026filed 6 May 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $56K2,688 at $20.68 | filing |
| 1 May 2026filed 4 May 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $62K2,873 at $21.50 | filing |
| 1 May 2026filed 4 May 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $62K2,873 at $21.50 | filing |
| 6 Apr 2026filed 7 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $34K1,892 at $17.82 | filing |
| 6 Apr 2026filed 7 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $34K1,892 at $17.82 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $71K3,987 at $17.87 | filing |
| 1 Apr 2026filed 3 Apr 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Code F | $71K3,987 at $17.87 | filing |
| 3 Feb 2026filed 4 Feb 2026 | CDNA CareDxDiagnostics & Labs | SEC FORM 4 Sold | $91K4,441 at $20.56 | filing |
News
Analyzing CollPlant Biotechnologies (NASDAQ:CLGN) and CareDx (NASDAQ:CDNA)CDNA · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Jeffrey Adam Novack; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.